Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical) - IKENA ONCOLOGY INC $ in Thousands |
12 Months Ended |
|---|---|
|
Dec. 31, 2023
USD ($)
| |
| Series A Non-Voting Convertible Preferred Stock | |
| Issuance costs | $ 991 |
| Common Stock | |
| Issuance costs | 430 |
| Underwritten Registered Offering | |
| Issuance costs | $ 2,605 |